Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22784116 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation
Conditions: Graft-versus-host Disease;   Hematopoietic Stem Cell Transplantation
Intervention: Drug: Maraviroc

Indicates status has not been verified in more than two years